AI assistant
Sending…
Purple Biotech Ltd. — Major Shareholding Notification 2020
Jan 3, 2020
7004_rns_2020-01-03_a127e344-621a-4eb1-bc7e-87558eace21a.htm
Major Shareholding Notification
Open in viewerOpens in your device viewer
_________ false
| ����� ����� ��"� | 2 381 |
| KITOV PHARMA LTD | |
| Corporation no: 520031238 | 10994 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 03/01/2020 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2020-02-001425 | Time of broadcast: 14:52 14:48:17 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | Schedule 13G/A filing with the SEC by Sabby Volatility Warrant Master Fund, Ltd. / Sabby Management, LLC / Hal Mintz concerning their holdings in the Company |
Kitov_Pharma_13GA_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 31/12/2019 |
| Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 , Israel Tel: 03-9333121 , Fax: 03-5097196 | |
| E-mail address: [email protected] Company site: www.kitovpharma.com | |
| Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD, | |
| Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company: ABZ Law Office | |
| Address: Yad Harutzim 15 , Jerusalem 9342152 Telephone: 079-5722070 Facsimile: 079-5722206 E-mail: [email protected] 1 | |
| Israel |
More from Purple Biotech Ltd.
Report Publication Announcement
2026
May 15
Earnings Release
2026
May 15
Regulatory Filings
2026
Apr 27
Report Publication Announcement
2026
Apr 27
Report Publication Announcement
2026
Apr 23
Regulatory Filings
2026
Apr 23
Director's Dealing
2026
Apr 18
Director's Dealing
2026
Apr 18
Director's Dealing
2026
Apr 17
Director's Dealing
2026
Apr 17